Formulation Optimization of Indomethacin Gels Containing a Combination of Three Kinds of Cyclic Monoterpenes as Percutaneous Penetration Enhancers

Okabe, 1989, Drug Des. Delivery, 4, 313 Okabe, 1990, Drug Des. Delivery, 6, 229 Obata, 1990, Drug Des. Delivery, 6, 319 Williams, 1991, Pharm. Res., 8, 17, 10.1023/A:1015813803205 Obata, 1991, Drug. Des. Discovery, 8, 137 Kaiho, 1987, Chem. Pharm. Bull., 35, 2928, 10.1248/cpb.35.2928 Ogiso, 1986, J. Pharmacobio-Dyn., 9, 517, 10.1248/bpb1978.9.517 Barry, 1989, Proc. Int. Symp. Control. Rel. Bioact. Mater., 16 Fonner, 1970, J. Pharm. Sci., 59, 1587, 10.1002/jps.2600591110 Schwartz, 1973, J. Pharm. Sci., 62, 1165, 10.1002/jps.2600620722 McLeod, 1988, J. Pharm. Sci., 77, 704, 10.1002/jps.2600770813 Fenyvesi, 1984, Chem. Pharm. Bull., 32, 670, 10.1248/cpb.32.670 Takayama, 1985, Chem. Pharm. Bull., 33, 292, 10.1248/cpb.33.292 Khuri, 1981, Technometrics, 23, 363, 10.1080/00401706.1981.10487681 Haga, 1976, Quality J. S. Q. C., 6, 35 Takayama, 1991, Int. J. Pharm., 74, 115, 10.1016/0378-5173(91)90228-G Yamaoka, 1981, J. Pharmacobio.-Dyn., 4, 879, 10.1248/bpb1978.4.879 Takayama, 1989, Chem. Pharm. Bull., 37, 160, 10.1248/cpb.37.160